Envoy Medical (Nasdaq: COCH) Nears Critical FDA Decision: Could Q1 2026 Spark Revenue Growth?
or investors following Envoy Medical (Nasdaq: COCH), the next six months may define the company’s future. With an FDA approval decision expected in late fourth quarter 2025 or early first…